- Home
- Publications
- Publication Search
- Publication Details
Title
Drug Repositioning for Effective Prostate Cancer Treatment
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-15
DOI
10.3389/fphys.2018.00500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans
- (2018) Adil Mardinoglu et al. Cell Metabolism
- Systems biology in hepatology: approaches and applications
- (2018) Adil Mardinoglu et al. Nature Reviews Gastroenterology & Hepatology
- Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells
- (2018) Igor Marín de Mas et al. PLoS Computational Biology
- Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study
- (2017) Mary K. Downer et al. EUROPEAN UROLOGY
- Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells
- (2017) Yoichi Iwamoto et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial
- (2017) Malcolm D. Mason et al. JOURNAL OF CLINICAL ONCOLOGY
- The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer
- (2017) Linh N.K. Tran et al. MOLECULAR CANCER THERAPEUTICS
- Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression
- (2017) Bilal Bin Hafeez et al. MOLECULAR CANCER THERAPEUTICS
- Personal model‐assisted identification of NAD + and glutathione metabolism as intervention target in NAFLD
- (2017) Adil Mardinoglu et al. Molecular Systems Biology
- Network analyses identify liver‐specific targets for treating liver diseases
- (2017) Sunjae Lee et al. Molecular Systems Biology
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
- (2017) Zdenek Skrott et al. NATURE
- TCSBN: a database of tissue and cancer specific biological networks
- (2017) Sunjae Lee et al. NUCLEIC ACIDS RESEARCH
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Repurposing itraconazole as an anticancer agent
- (2017) Hiroshi Tsubamoto et al. Oncology Letters
- Ferroquine, the next generation antimalarial drug, has antitumor activity
- (2017) Artem Kondratskyi et al. Scientific Reports
- Metformin and Prostate Cancer: a New Role for an Old Drug
- (2017) Jessica Whitburn et al. Current Urology Reports
- Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms
- (2017) Nadeem Bilani et al. Frontiers in Pharmacology
- On the Integration of In Silico Drug Design Methods for Drug Repurposing
- (2017) Eric March-Vila et al. Frontiers in Pharmacology
- The Metabolic Phenotype of Prostate Cancer
- (2017) Eric Eidelman et al. Frontiers in Oncology
- Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance
- (2016) Sunjae Lee et al. Cell Metabolism
- An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
- (2016) Deepak Bhattarai et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
- (2016) Roberto Würth et al. DRUG DISCOVERY TODAY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- In silico methods for drug repurposing and pharmacology
- (2016) Rachel A. Hodos et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing
- (2016) QI ZHANG et al. Oncology Letters
- The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo
- (2016) Annelies Gonnissen et al. Oncotarget
- A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors
- (2016) Kaitlyn M. Gayvert et al. Cell Reports
- Applications of Genome-Scale Metabolic Models in Biotechnology and Systems Medicine
- (2016) Cheng Zhang et al. Frontiers in Physiology
- Metabolic Network Prediction of Drug Side Effects
- (2016) Itay Shaked et al. Cell Systems
- Phosphoproteome Analysis of Invasion and Metastasis-Related Factors in Pancreatic Cancer Cells
- (2016) Xiaodong Tan et al. PLoS One
- Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis
- (2016) Cuiling Qi et al. Scientific Reports
- Zoledronic acid in the management of metastatic bone disease
- (2016) Thomas Polascik Therapeutics and Clinical Risk Management
- Targeting the lysosome in cancer
- (2015) Shengfu Piao et al. Annals of the New York Academy of Sciences
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome
- (2015) Saeed Shoaie et al. Cell Metabolism
- New paradigms for metabolic modeling of human cells
- (2015) Adil Mardinoglu et al. CURRENT OPINION IN BIOTECHNOLOGY
- Computational Drug Repositioning for Cancer Therapeutics
- (2015) Mingkun Jiao et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes
- (2015) Tao Xu et al. DIABETES CARE
- Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1
- (2015) Jae Eun Lee et al. GENETICS AND MOLECULAR BIOLOGY
- The Use of Aspirin and the Risk of Mortality in Patients with Prostate Cancer
- (2015) Jonathan Assayag et al. JOURNAL OF UROLOGY
- Modeling cancer metabolism on a genome scale
- (2015) K. Yizhak et al. Molecular Systems Biology
- Emerging strategies to effectively target autophagy in cancer
- (2015) V W Rebecca et al. ONCOGENE
- Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer – a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
- (2015) Wei-Ling Chang et al. Oncotarget
- Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer
- (2015) Min Guan et al. Scientific Reports
- Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: Comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex
- (2015) Suhong Yu et al. Scientific Reports
- Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling
- (2015) Pouyan Ghaffari et al. Scientific Reports
- The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer
- (2015) Martin C. Sadowski et al. Oncotarget
- Teriflunomide (Leflunomide) Promotes Cytostatic, Antioxidant, and Apoptotic Effects in Transformed Prostate Epithelial Cells: Evidence Supporting a Role for Teriflunomide in Prostate Cancer Chemoprevention
- (2015) Numsen Hail et al. NEOPLASIA
- A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders
- (2014) David R. Gastfriend Annals of the New York Academy of Sciences
- Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis
- (2014) Yanqiong Liu et al. BMC Medicine
- Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer
- (2014) Minghua Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling
- (2014) Jill Gallaher et al. CLINICAL & EXPERIMENTAL METASTASIS
- Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study
- (2014) A. C. Vidal et al. CLINICAL CANCER RESEARCH
- Metformin Use and Prostate Cancer Risk
- (2014) Mark A. Preston et al. EUROPEAN UROLOGY
- Could valproic acid be an effective anticancer agent? The evidence so far
- (2014) Seth A Brodie et al. Expert Review of Anticancer Therapy
- Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
- (2014) Joong Sup Shim et al. International Journal of Biological Sciences
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling
- (2014) R. Agren et al. Molecular Systems Biology
- A Phase II Clinical Trial of Oral Valproic Acid in Patients with Castration-Resistant Prostate Cancers Using an Intensive Biomarker Sampling Strategy
- (2014) Sunil Sharma et al. Translational Oncology
- Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease
- (2014) Adil Mardinoglu et al. Nature Communications
- Evaluating the Cancer Therapeutic Potential of Cardiac Glycosides
- (2014) José Manuel Calderón-Montaño et al. Biomed Research International
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Acute Infection Induces a Metastatic Niche: A Double Menace for Cancer Patients
- (2013) H. A. Smith et al. CLINICAL CANCER RESEARCH
- Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention
- (2013) Soren Gantt et al. CURRENT OPINION IN ONCOLOGY
- The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting
- (2013) Chin-Chen Chu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials
- (2013) M. Slingerland et al. INVESTIGATIONAL NEW DRUGS
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes
- (2013) David Margel et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer
- (2013) Charles M. Rudin et al. Journal of Thoracic Oncology
- Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
- (2013) E. S. Antonarakis et al. ONCOLOGIST
- Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies
- (2013) Parvin Ataie-Kachoie et al. PLoS One
- New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
- (2013) Eva Gottfried et al. PLoS One
- Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
- (2013) Yu-Chi Wang et al. PLoS One
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer
- (2013) M T Schweizer et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Cancer drug discovery by repurposing: teaching new tricks to old dogs
- (2013) Subash C. Gupta et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Striking Growth-inhibitory Effects of Minocycline on Human Prostate Cancer Cell Lines
- (2013) Francesca Regen et al. UROLOGY
- Model-based identification of drug targets that revert disrupted metabolism and its application to ageing
- (2013) Keren Yizhak et al. Nature Communications
- Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model
- (2013) Takeshi Inoue et al. BMC Urology
- Understanding drugs and diseases by systems biology?
- (2012) Hans-Christoph Schneider et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of a 17β-Hydroxysteroid Dehydrogenase Type 10 Steroidal Inhibitor: A Tool to Investigate the Role of Type 10 in Alzheimer’s Disease and Prostate Cancer
- (2012) Diana Ayan et al. ChemMedChem
- Targeting Aldose Reductase for the Treatment of Cancer
- (2012) R. Tammali et al. CURRENT CANCER DRUG TARGETS
- Development of New Cathepsin B Inhibitors: Combining Bioisosteric Replacements and Structure-Based Design To Explore the Structure–Activity Relationships of Nitroxoline Derivatives
- (2012) Izidor Sosič et al. JOURNAL OF MEDICINAL CHEMISTRY
- Growth Inhibition of Ovarian Tumor-Initiating Cells by Niclosamide
- (2012) Y.-T. Yo et al. MOLECULAR CANCER THERAPEUTICS
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- miRNA-mRNA Correlation-Network Modules in Human Prostate Cancer and the Differences between Primary and Metastatic Tumor Subtypes
- (2012) Wensheng Zhang et al. PLoS One
- Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT
- (2012) Rasmus Agren et al. PLoS Computational Biology
- Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
- (2012) Jing-Xuan Pan et al. Chinese Journal of Cancer
- Progress of molecular targeted therapies for prostate cancers
- (2011) Weihua Fu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression
- (2011) Chelsea R Tieszen et al. BMC CANCER
- A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol
- (2011) J Shamash et al. BRITISH JOURNAL OF CANCER
- Statin use and fatal prostate cancer
- (2011) Stephen W. Marcella et al. CANCER
- A Novel Method of Transcriptional Response Analysis to Facilitate Drug Repositioning for Cancer Therapy
- (2011) G. Jin et al. CANCER RESEARCH
- Itraconazole Inhibits Angiogenesis and Tumor Growth in Non-Small Cell Lung Cancer
- (2011) B. T. Aftab et al. CANCER RESEARCH
- Systems medicine and metabolic modelling
- (2011) A. Mardinoglu et al. JOURNAL OF INTERNAL MEDICINE
- Drug repositioning: Re-investigating existing drugs for new therapeutic indications
- (2011) BM Padhy et al. Journal of Postgraduate Medicine
- Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
- (2011) U. Sack et al. JNCI-Journal of the National Cancer Institute
- Statin Use and Risk of Prostate Cancer in a Population of Men Who Underwent Biopsy
- (2011) Nelly Tan et al. JOURNAL OF UROLOGY
- Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform
- (2011) Ramesh Ummanni et al. PLoS One
- Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
- (2011) Wenyan Lu et al. PLoS One
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
- (2011) R. Huang et al. Science Translational Medicine
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
- (2011) M. Sirota et al. Science Translational Medicine
- Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia
- (2011) Naoya Masumori Therapeutics and Clinical Risk Management
- Exogenous and endogenous glucocorticoids in rheumatic diseases
- (2010) Frank Buttgereit et al. ARTHRITIS AND RHEUMATISM
- Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE
- (2010) Matthew S. Katz et al. BJU INTERNATIONAL
- Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
- (2010) James Kim et al. CANCER CELL
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: A meta-analysis
- (2010) Salaheddin M. Mahmud et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer
- (2010) Joong Sup Shim et al. JNCI-Journal of the National Cancer Institute
- RelB-Dependent Differential Radiosensitization Effect of STI571 on Prostate Cancer Cells
- (2010) Yong Xu et al. MOLECULAR CANCER THERAPEUTICS
- Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers☆
- (2010) Bal L. Lokeshwar PHARMACOLOGICAL RESEARCH
- Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
- (2010) Jianqing Lin et al. PROSTATE
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review
- (2009) Kate E. Schemmel et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia
- (2009) RM Abou El-Magd et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Association of Nonsteroidal Anti-Inflammatory Drugs, Prostate Specific Antigen and Prostate Volume
- (2009) Jay H. Fowke et al. JOURNAL OF UROLOGY
- Digoxin, HIF-1, and cancer
- (2009) M. Lopez-Lazaro PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones
- (2008) Mary-Ellen Taplin et al. BJU INTERNATIONAL
- Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth
- (2008) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now